Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Sun Yat-sen University Cancer Center

Sun Yat-sen University Cancer Center in Guangzhou, Guangdong, China is listed as a site for 1,147 registered clinical trials, 570 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,147
Ongoing 570

This page covers the site record Sun Yat-sen University Cancer Center in Guangzhou, Guangdong, China: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Sun Yat-sen University Cancer Center, also sponsors trials.

Get the Sun Yat-sen University Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,147 trials counted.

  • Phase 1 160 trials
  • Phase 1/2 126 trials
  • Phase 2 405 trials
  • Phase 2/3 23 trials
  • Phase 3 260 trials
  • Phase 4 9 trials
  • Not applicable 68 trials
  • Observational 96 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 570 trials
  • Completed 212 trials
  • Terminated 75 trials
  • Other 290 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 142

2002: 2 trials (Observational 1, Phase 2/3 1) 2005: 1 trials (Not applicable 1) 2006: 4 trials (Observational 1, Phase 3 2, Phase 2 1) 2008: 6 trials (Observational 1, Phase 3 3, Phase 2 2) 2009: 6 trials (Phase 3 2, Phase 2 3, Phase 1 1) 2010: 5 trials (Not applicable 1, Phase 3 1, Phase 2 3) 2011: 10 trials (Not applicable 2, Phase 4 1, Phase 3 1, Phase 2 3, Phase 1 3) 2012: 13 trials (Observational 1, Phase 3 5, Phase 2/3 1, Phase 2 5, Phase 1/2 1) 2013: 22 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 3 6, Phase 2 10, Phase 1 1) 2014: 27 trials (Observational 5, Not applicable 1, Phase 3 10, Phase 2/3 1, Phase 2 4, Phase 1/2 3, Phase 1 3) 2015: 52 trials (Observational 1, Not applicable 7, Phase 4 2, Phase 3 19, Phase 2/3 2, Phase 2 17, Phase 1/2 2, Phase 1 2) 2016: 35 trials (Observational 2, Not applicable 5, Phase 3 10, Phase 2 13, Phase 1/2 3, Phase 1 2) 2017: 46 trials (Observational 17, Not applicable 8, Phase 3 7, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 6) 2018: 51 trials (Observational 3, Not applicable 1, Phase 4 1, Phase 3 17, Phase 2/3 2, Phase 2 17, Phase 1/2 2, Phase 1 8) 2019: 75 trials (Observational 14, Not applicable 3, Phase 3 14, Phase 2/3 1, Phase 2 29, Phase 1/2 7, Phase 1 7) 2020: 83 trials (Observational 2, Not applicable 10, Phase 3 17, Phase 2 35, Phase 1/2 9, Phase 1 10) 2021: 102 trials (Observational 10, Not applicable 2, Phase 4 1, Phase 3 20, Phase 2/3 1, Phase 2 41, Phase 1/2 11, Phase 1 16) 2022: 92 trials (Observational 10, Not applicable 5, Phase 3 17, Phase 2 32, Phase 1/2 10, Phase 1 18) 2023: 104 trials (Observational 7, Not applicable 5, Phase 4 3, Phase 3 24, Phase 2/3 1, Phase 2 33, Phase 1/2 16, Phase 1 15) 2024: 135 trials (Observational 10, Not applicable 7, Phase 3 22, Phase 2/3 3, Phase 2 47, Phase 1/2 15, Phase 1 31) 2025: 142 trials (Observational 3, Not applicable 3, Phase 3 36, Phase 2/3 3, Phase 2 47, Phase 1/2 26, Phase 1 24)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 134
2025 142
2024 135
2023 104
2022 92
2021 102
2020 83
2019 75
2018 51
2017 46

Showing 10 of 22 years.

Start your 14-day trial Email me all 22 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,147 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 164 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 176 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF